You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 17, Issue 6

March-2 2025 - 141 articles

Cover Story: In the following study, patients with metastatic, non-oncogene-addicted NSCLC received anti-PD1-based therapies. These treatments targeted various immune system components and affected the interactions among these factors to differing degrees. Responding patients with better clinical status exhibited an immune profile characterized by low connections primarily among soluble checkpoints at baseline. Non-responders with worse clinical status showed a complex immune network involving inflammatory cytokines, cellular components, and soluble checkpoints. Defining the connectivity among the molecules of each profile serves as an optimal starting point for developing combinatory targeted drugs aimed at optimizing therapeutic strategies and avoiding unnecessary and toxic treatments. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (141)

  • Review
  • Open Access
2 Citations
2,186 Views
21 Pages

The Current Role of Circulating Cell-Free DNA in the Management of Hepatocellular Carcinoma

  • Alkistis Papatheodoridi,
  • Vasileios Lekakis,
  • Antonios Chatzigeorgiou and
  • George Papatheodoridis

20 March 2025

Circulating cell-free DNA (cfDNA) has emerged as a compelling candidate of liquid biopsy markers for the diagnosis and prognosis of several cancers. We systematically reviewed data on the role of cfDNA markers in the diagnosis, prognosis and treatmen...

  • Review
  • Open Access
3 Citations
2,259 Views
19 Pages

Unlocking the Potential of ctDNA in Sarcomas: A Review of Recent Advances

  • Sahana Aiyer,
  • Tae-Hee Kim,
  • Katharine Collier,
  • Raphael Pollock,
  • Claire Verschraegen,
  • Daniel G. Stover and
  • Gabriel Tinoco

20 March 2025

Soft tissue sarcomas (STSs) constitute a group of tumors with heterogeneous alterations and different biological behavior. Genetic profiling techniques have immense potential to revolutionize sarcoma classification, detection, and treatment. Cell-fre...

  • Review
  • Open Access
8 Citations
3,953 Views
29 Pages

CDK4/6 as a Therapeutic Target in HR+/HER2− Breast Cancer Cells—Current Treatment Status

  • Kamila Krupa,
  • Anna Liszcz-Tymoszuk,
  • Natalia Czerw,
  • Aleksandra Czerw,
  • Katarzyna Sygit,
  • Remigiusz Kozłowski,
  • Andrzej Deptała and
  • Anna Badowska-Kozakiewicz

20 March 2025

Breast cancer is the most frequently diagnosed neoplasm in the world. It can be classified into four main subtypes, each of them showing differences in the expression of hormone receptor (HR), human epidermal growth factor receptor 2 (HER2), and in c...

  • Article
  • Open Access
1 Citations
1,411 Views
12 Pages

Design of a Phase I Drug Combination Study with Adaptive Allocation Based on Dose-Limiting Toxicity Attribution

  • Nolan A. Wages,
  • Bethany J. Horton,
  • Li Liu,
  • Enrica Marchi and
  • Gina R. Petroni

20 March 2025

Background: This article describes the adaptation of a Phase I drug combination method to incorporate dose-limiting toxicity (DLT) attribution in dose assignments. The study is motivated by the Embolden trial (NCT03240211), a Phase Ib, multicenter tr...

  • Article
  • Open Access
2,917 Views
17 Pages

Loss of ING3 in the Prostate Leads to Activation of DNA Damage Repair Markers

  • Viktor Lang,
  • Lisa Barones,
  • ShiTing Misaki Hu,
  • Fatemeh Hashemi,
  • Karen Blote,
  • Karl Riabowol and
  • Dieter Fink

20 March 2025

Background/Objectives: The inhibitor of growth family member 3 (ING3) acts as an epigenetic reader through physical interactions with histone-modifying enzymes and subsequent chromatin remodelling processes. It is involved in various cellular functio...

  • Article
  • Open Access
1,127 Views
18 Pages

Temporal Validation of an FDG-PET-Radiomic Model for Distant-Relapse-Free-Survival After Radio-Chemotherapy for Pancreatic Adenocarcinoma

  • Monica Maria Vincenzi,
  • Martina Mori,
  • Paolo Passoni,
  • Roberta Tummineri,
  • Najla Slim,
  • Martina Midulla,
  • Gabriele Palazzo,
  • Alfonso Belardo,
  • Emiliano Spezi and
  • Maria Picchio
  • + 5 authors

20 March 2025

Background/Objectives: Pancreatic cancer is a very aggressive disease with a poor prognosis, even when diagnosed at an early stage. This study aimed to validate and refine a radiomic-based [18F]FDG-PET model to predict distant relapse-free survival (...

  • Article
  • Open Access
3 Citations
1,837 Views
22 Pages

Trends in Endometrial Cancer Incidence Among Premenopausal and Postmenopausal Women in the United States Between 2001 and 2021

  • Fangjian Guo,
  • Victor Adekanmbi,
  • Christine D. Hsu,
  • Thao N. Hoang,
  • Pamela T. Soliman,
  • Jacques G. Baillargeon and
  • Abbey B. Berenson

20 March 2025

Background: Endometrial cancer incidence has been rising in the United States. We assessed trends in endometrial cancer incidence among both premenopausal and postmenopausal women in the US from 2001 to 2021. We also compared the incidence during 201...

  • Article
  • Open Access
1,425 Views
23 Pages

Exploring the Expression of CD73 in Lung Adenocarcinoma with EGFR Genomic Alterations

  • Elodie Long-Mira,
  • Christophe Bontoux,
  • Guylène Rignol,
  • Véronique Hofman,
  • Sandra Lassalle,
  • Jonathan Benzaquen,
  • Jacques Boutros,
  • Salomé Lalvée-Moret,
  • Katia Zahaf and
  • Virginie Lespinet-Fabre
  • + 9 authors

20 March 2025

Background/Objectives: Immune checkpoint inhibitors (ICIs) benefit some lung cancer patients, but their efficacy is limited in advanced lung adenocarcinoma (LUAD) with EGFR mutations (EGFRm), largely due to a non-immunogenic tumour microenvironment (...

  • Article
  • Open Access
1,391 Views
10 Pages

The Impact of Surgical Conization of the Cervix and Loop Electrosurgical Excision Procedure on Female Sexual Function

  • Paweł Bartnik,
  • Joanna Kacperczyk-Bartnik,
  • Anna Różańska-Walędziak,
  • Andrzej Wróbel,
  • Christopher Kobierzycki,
  • Krzysztof Czajkowski and
  • Ewa Romejko-Wolniewicz

20 March 2025

Objectives: The aim of the study was to analyze and compare the possible effect of cervical conization and the loop electrosurgical excision procedure (LEEP) on female sexual function up to one year after intervention, as existing studies provide inc...

  • Review
  • Open Access
1 Citations
3,312 Views
18 Pages

20 March 2025

Camptothecin and its derivatives (CPTs) are potent antineoplastic agents that exert their effects by inhibiting DNA topoisomerase I, leading to apoptosis during cell proliferation. Since their discovery in the 1960s, CPTs have faced challenges such a...

of 15

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694Creative Common CC BY license